GÖKSU EROL, A. Y. Et Al. 2011. F48.Clinicopathologic Significance of VEGF and COX-2 Expressions of Cancer Cells and Tumor Stroma in Endometrial Carcinoma. Federation of Clinical Immunology Societies, 11th Annual Meeting , (Washington Dc., United States Of America), 124-125.

GÖKSU EROL, A. Y., Tokyol, Ç., Özdemir, Ö., Yılmazer, M., Arıöz, T. D., & Aktepe, F., (2011). F48.Clinicopathologic Significance of VEGF and COX-2 Expressions of Cancer Cells and Tumor Stroma in Endometrial Carcinoma . Federation of Clinical Immunology Societies, 11th Annual Meeting (pp.124-125). Washington Dc., United States Of America

GÖKSU EROL, AZİZE Et Al. "F48.Clinicopathologic Significance of VEGF and COX-2 Expressions of Cancer Cells and Tumor Stroma in Endometrial Carcinoma," Federation of Clinical Immunology Societies, 11th Annual Meeting, Washington Dc., United States Of America, 2011

GÖKSU EROL, AZİZE Y. Et Al. "F48.Clinicopathologic Significance of VEGF and COX-2 Expressions of Cancer Cells and Tumor Stroma in Endometrial Carcinoma." Federation of Clinical Immunology Societies, 11th Annual Meeting , Washington Dc., United States Of America, pp.124-125, 2011

GÖKSU EROL, A. Y. Et Al. (2011) . "F48.Clinicopathologic Significance of VEGF and COX-2 Expressions of Cancer Cells and Tumor Stroma in Endometrial Carcinoma." Federation of Clinical Immunology Societies, 11th Annual Meeting , Washington Dc., United States Of America, pp.124-125.

@conferencepaper{conferencepaper, author={AZİZE YASEMİN GÖKSU EROL Et Al. }, title={F48.Clinicopathologic Significance of VEGF and COX-2 Expressions of Cancer Cells and Tumor Stroma in Endometrial Carcinoma}, congress name={Federation of Clinical Immunology Societies, 11th Annual Meeting}, city={Washington Dc.}, country={United States Of America}, year={2011}, pages={124-125} }